ロード中...
Ticagrelor breaks up the tumor-platelet party
In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ova...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606010/ https://ncbi.nlm.nih.gov/pubmed/28882833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-795898 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|